Antimicrobial resistance of Staphylococcus spp. from human specimens submitted to diagnostic laboratories in South Africa, 2012–2017

Show simple item record

dc.contributor.author Sigudu, Themba Titus
dc.contributor.author Oguttu, James Wabwire
dc.contributor.author Qekwana, Daniel N.
dc.date.accessioned 2025-02-17T07:41:21Z
dc.date.available 2025-02-17T07:41:21Z
dc.date.issued 2024-09-09
dc.description DATA AVAILABILITY STATEMENT : The data supporting this study’s findings are available upon reasonable request and subject to specific conditions. For data access inquiries, including requests for collaboration or data-sharing agreements, please contact Thomas Papo, data analyst, at thomas.papo@nhls.ac.za. Requests will be evaluated on a case-by-case basis, considering the request’s nature, compliance with relevant regulations, and any associated agreements or protocols. en_US
dc.description.abstract Antimicrobial resistance (AMR) poses a significant worldwide health challenge associated with prolonged illnesses, increased healthcare costs, and high mortality rates. The present study examined the patterns and predictors of AMR among human Staphylococcus isolates obtained from diagnostic laboratories in South Africa between 2012 and 2017. This study examined data from 404 217 isolates, assessing resistance rates across different characteristics such as age, sample origin, Staphylococcus species, and study period. The highest resistance was observed against cloxacillin (70.3%), while the lowest resistance was against Colistin (0.1%). A significant (p < 0.05) decreasing trend in AMR was observed over the study period, while a significant increasing temporal trend (p < 0.05) was observed for multidrug resistance (MDR) over the same period. A significant (p < 0.05) association was observed between specimen type, species of organism, and year of isolation with AMR outcome. Significant (p < 0.05) associations were observed between specimen type and season with MDR. The observed high levels of AMR and a growing trend in MDR are concerning for public health. Clinicians should take these findings into account when deciding on therapeutic options. Continued monitoring of AMR among Staphylococcus spp. and judicious use of antimicrobials in human medicine should be promoted. en_US
dc.description.department Paraclinical Sciences en_US
dc.description.librarian am2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.uri https://www.mdpi.com/journal/microorganisms en_US
dc.identifier.citation Sigudu, T.T.; Oguttu, J.W.; Qekwana, D.N. Antimicrobial Resistance of Staphylococcus spp. from Human Specimens Submitted to Diagnostic Laboratories in South Africa, 2012–2017. Microorganisms 2024, 12, 1862. https://DOI.org/10.3390/microorganisms12091862. en_US
dc.identifier.issn 2076-2607
dc.identifier.other 10.3390/microorganisms12091862
dc.identifier.uri http://hdl.handle.net/2263/100969
dc.language.iso en en_US
dc.publisher MDPI en_US
dc.rights © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. en_US
dc.subject Staphylococcus en_US
dc.subject Isolates en_US
dc.subject Human en_US
dc.subject Species en_US
dc.subject Antimicrobial resistance (AMR) en_US
dc.subject Multidrug resistance (MDR) en_US
dc.subject South Africa (SA) en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title Antimicrobial resistance of Staphylococcus spp. from human specimens submitted to diagnostic laboratories in South Africa, 2012–2017 en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record